Lazcluze 57894-0240-99
Generic: Lazertinib
- Manufacturer
- Janssen Biotech, Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 20, 2024
- Listing Expires
- December 31, 2027
- Application
- NDA219008
Need to source Lazcluze? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lazertinib | 240 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Breast Cancer Resistance Protein Inhibitors [MoA]Cytochrome P450 3A4 Inhibitors [MoA]
Selected Package
57894-0240-99Selected1 DOSE PACK in 1 CARTON (57894-240-99) / 14 TABLET, FILM COATED in 1 DOSE PACK
Other packages for this product(1)
1 BOTTLE in 1 CARTON (57894-240-30) / 30 TABLET, FILM COATED in 1 BOTTLE